On the Record · Allergan
Allergan competitors, on the record
The companies Allergan names as competitors in its annual reports, 2017 to 2019, and the companies that name Allergan, each with the sentence and the filing.
Who Allergan names
| Company | Named in |
|---|---|
| Sandoz | 2019 |
| Shire | 2019 |
In its own words
Sandoz
Word for word“For example, Sandoz launched “at risk” a generic version of Latisse ® in December 2016; litigation concerning that launch is ongoing, and Sandoz continues to market its generic product.” 10-K for 2019
Shire
Word for word“F-79 Restasis ® Competitor Litigation . Shire, which offers the dry-eye disease drug Xiidra ® , sued subsidiaries of the Company in U.S.” 10-K for 2019
Who names Allergan
Companies whose own annual reports name Allergan as a competitor.
Word for word“Our competitors for TT include Smith & Nephew plc, Organogenesis Holdings Inc., MiMedx Group, Inc., Allergan PLC, Becton Dickinson and Company, and Axogen, Inc.” 10-K for 2025
Word for word“XIIDRA competes against Allergan's RESTASIS (a prescription topical immunomodulator indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca) and various over the counter artificial tear products.” 10-K for 2017
Read from Allergan’s annual reports (10-K for 2019, 10-K for 2018, 10-K for 2017) and the financial data it files with the SEC, as of 2020-02-18. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.